Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CardioComm SolutionsEKGGF EV-to-OCF is -4.16 as of Sep. 16, 2026. The stock has 7 warning signs investors should review. Among 685 Healthcare Providers & Services companies, CardioComm Solutions ranks better than 78.83% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, CardioComm Solutions's Enterprise Value is $1.36 Mil.
CardioComm Solutions's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.33 Mil. Therefore, CardioComm Solutions's EV-to-OCF for today is -4.16.
The historical rank and industry rank for CardioComm Solutions's EV-to-OCF or its related term are showing as below:
EKGGF'
s EV-to-OCF Range Over the Past 10 Years
Min: -736.68 Med: -22.71 Max: 227.29
Current: -4.13
During the past 13 years, the highest EV-to-OCF of CardioComm Solutions was 227.29. The lowest was -736.68. And the median was -22.71.
EKGGF's EV-to-OCF is ranked better than 78.83% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 8.65
vs EKGGF: -4.13
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CardioComm Solutions's PE Ratio (TTM) for today is calculated as:
CardioComm Solutions's share price for today is $0.01.
CardioComm Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.002.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
CardioComm Solutions EV-to-OCF Related Terms
CardioComm Solutions EV-to-OCF Historical Data
* Premium members only.
The historical data trend for CardioComm Solutions's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, CardioComm Solutions's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CardioComm Solutions EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CardioComm Solutions's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where CardioComm Solutions's EV-to-OCF falls into.
CardioComm Solutions's current Enterprise Value is $1.36 Mil.
CardioComm Solutions's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.33 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CardioComm Solutions (EKGGF) has a EV-to-OCF of -4.16 as of Sep. 16, 2026. According to the industry distribution chart, CardioComm Solutions ranks #145 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 21.2%.
Is CardioComm Solutions' EV-to-OCF too high?
CardioComm Solutions' current EV-to-OCF is -4.16. Based on the distribution chart, CardioComm Solutions ranks #145 out of 685 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does CardioComm Solutions' EV-to-OCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, CardioComm Solutions ranks #145 out of 685 companies for EV-to-OCF. This places CardioComm Solutions in the top 21% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 8.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.65, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CardioComm Solutions's current EV-to-OCF is -4.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CardioComm Solutions stock overvalued right now?
CardioComm Solutions (EKGGF) has a current EV-to-OCF of -4.16. The current EV-to-OCF is -4.16. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For CardioComm Solutions (EKGGF), the current EV-to-OCF is -4.16 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CardioComm Solutions Inc develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company has one operating segment, which involves the development of software and the sale of ECG recording equipment and ECG reading services for the cardiology field. Substantially all the Company's operations, assets, and employees are in Canada. Revenue is earned in Canada and the United States. Its products are GEMS Sirona, GEMS WIN, Trident Pro 40L, HeartCheck CardiBeat - Mobile ECG Device, HeartCheck SMART Monitoring, and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKGGF has been successfully added to your 
